New Prognostic Index for Burkitt Lymphoma

  Andrew M. Evens, DO, Director of the Lymphoma Program at Rutgers Cancer Institute and Medical Director of the Oncology Service Line at RWJBarnabas Health, talks about New Prognostic Indicator for Burkitt Lymphoma. Burkitt lymphoma is a rare, and very...

Is It Safe For Pregnant Fabry Patients to Continue ERT?

  Dawn Laney, MS, CGC, CCRC, Assistant Professor, and Director of Emory Genetic Clinical Trials Center, discusses research confirming the safety of Fabry patients continuing enzyme replacement therapy (ERT) during pregnancy.  Fabry disease is a rare X-linked...

Telling New Parents About a Rare Disease Diagnosis: SMA

  Regina Philipps, mother of a three-year-old diagnosed with spinal muscular atrophy (SMA), discusses what she would like clinicians to talk about with parents of recently diagnosed SMA. Ms. Philipps, who learned of the diagnosis when her child was 10 months old,...